Related references
Note: Only part of the references are listed.Increased De Novo Lipogenesis Is a Distinct Characteristic of Individuals With Nonalcoholic Fatty Liver Disease
Jennifer E. Lambert et al.
GASTROENTEROLOGY (2014)
Expression of Aldo-Keto Reductase Family 1 Member B10 in the Early Stages of Human Hepatocarcinogenesis
Hironori Tsuzura et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2014)
Role of Pregnane X Receptor in Obesity and Glucose Homeostasis in Male Mice
Krisstonia Spruiell et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Pregnane X Receptor Agonists Impair Postprandial Glucose Tolerance
J. Rysa et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2013)
PXR Ablation Alleviates Diet-Induced and Genetic Obesity and Insulin Resistance in Mice
Jinhan He et al.
DIABETES (2013)
PXR cross-talks with internal and external signals in physiological and pathophysiological responses
Susumu Kodama et al.
DRUG METABOLISM REVIEWS (2013)
Effects of atorvastatin metabolites on induction of drug-metabolizing enzymes and membrane transporters through human pregnane X receptor
E. Hoffart et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Gene Expression Profiling Unravels Cancer-Related Hepatic Molecular Signatures in Steatohepatitis but Not in Steatosis
Julia Starmann et al.
PLOS ONE (2012)
Nuclear Receptors as New Perspective for the Management of Liver Diseases
Michael Trauner et al.
GASTROENTEROLOGY (2011)
Nuclear Receptors in Liver Disease
Martin Wagner et al.
HEPATOLOGY (2011)
Role of high-fat diet in regulation of gene expression of drug metabolizing enzymes and transporters
Romi Ghose et al.
LIFE SCIENCES (2011)
Regulation of drug-metabolizing enzymes by xenobiotic receptors: PXR and CAR
Antonia H. Tolson et al.
ADVANCED DRUG DELIVERY REVIEWS (2010)
Murine aldo-keto reductase family 1 subfamily B: identification of AKR1B8 as an ortholog of human AKR1B10
Amit Joshi et al.
BIOLOGICAL CHEMISTRY (2010)
ChIPing the cistrome of PXR in mouse liver
Julia Yue Cui et al.
NUCLEIC ACIDS RESEARCH (2010)
The nuclear receptor PXR gene variants are associated with liver injury in nonalcoholic fatty liver disease
Silvia Sookoian et al.
PHARMACOGENETICS AND GENOMICS (2010)
Lipid Droplets Finally Get a Little R-E-S-P-E-C-T
Robert V. Farese et al.
CELL (2009)
A Novel Pregnane X Receptor and S14-Mediated Lipogenic Pathway in Human Hepatocyte
Amelie Moreau et al.
HEPATOLOGY (2009)
Expression of Organic Cation Transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) Is Affected by Genetic Factors and Cholestasis in Human Liver
Anne T. Nies et al.
HEPATOLOGY (2009)
Aldo-keto Reductase Family 1 Member B10 Promotes Cell Survival by Regulating Lipid Synthesis and Eliminating Carbonyls
Chun Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Hepatic Lipid Partitioning and Liver Damage in Nonalcoholic Fatty Liver Disease ROLE OF STEAROYL-CoA DESATURASE
Zheng Zheng Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Nonalcoholic Steatohepatitis Is Associated with Altered Hepatic MicroRNA Expression
Onpan Cheung et al.
HEPATOLOGY (2008)
Post-transcriptional regulation of human pregnane x receptor by micro-RNA affects the expression of cytochrome P450 3A4
Shingo Takagi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Pharmacologic inhibition of site 1 protease activity inhibits sterol regulatory element-binding protein processing and reduces lipogenic enzyme gene expression and lipid synthesis in cultured cells and experimental animals
Julie L. Hawkins et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Nonalcoholic fatty liver disease: Pathogenesis and potential for nuclear receptors as therapeutic targets
Jacob George et al.
MOLECULAR PHARMACEUTICS (2008)
Molecular mechanisms and therapeutic targets in steatosis and steatohepatitis
Nora Anderson et al.
PHARMACOLOGICAL REVIEWS (2008)
Genome-Wide Occupancy of SREBP1 and Its Partners NFY and SP1 Reveals Novel Functional Roles and Combinatorial Regulation of Distinct Classes of Genes
Brian D. Reed et al.
PLOS GENETICS (2008)
Pregnane X receptor is essential for normal progression of liver regeneration
Guoli Dai et al.
HEPATOLOGY (2008)
Aldo-keto reductase family 1 B10 affects fatty acid synthesis by regulating the stability of acetyl-CoA carboxylase-α in breast cancer cells
Jun Ma et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Reciprocal regulation of the human sterol regulatory element binding protein (SREBP)-1a promoter by Sp1 and EGR-1 transcription factors
Ana Fernandez-Alvarez et al.
FEBS LETTERS (2008)
Nonalcoholic fatty liver disease as a complication of insulin resistance
Manal F. Abdelmalek et al.
MEDICAL CLINICS OF NORTH AMERICA (2007)
Nuclear pregnane X receptor cross-talk with FoxA2 to mediate drug-induced regulation of lipid metabolism in fasting mouse liver
Kouichi Nakamura et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
The dietary isothiocyanate sulforaphane is an antagonist of the human steroid and xenobiotic nuclear receptor
Changcheng Zhou et al.
MOLECULAR PHARMACOLOGY (2007)
Insulin activates human sterol-regulatory-element-binding protein-1c (SREBP-1c) promoter through SRE motifs
Nicolas Dif et al.
BIOCHEMICAL JOURNAL (2006)
A novel pregnane X receptor-mediated and sterol regulatory element-binding protein-independent lipogenic pathway
Jie Zhou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Control of lipid metabolism by phosphorylation-dependent degradation of the SREBP family of transcription factors by SCFFbw7
A Sundqvist et al.
CELL METABOLISM (2005)
Mechanisms of disease: pathogenesis of nonalcoholic fatty liver disease
AJ Sanyal
NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY (2005)
Molecular mechanisms of polymorphic CYP3A7 expression in adult human liver and intestine
O Burk et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Nuclear receptor response elements mediate induction of intestinal MDR1 by rifampin
A Geick et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Share Paper
